Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure
Research output: Contribution to journal › Journal article › Research › peer-review
| Original language | English |
|---|---|
| Journal | Journal of Cardiac Failure |
| Volume | 27 |
| Issue number | 11 |
| Pages (from-to) | 1291-1294 |
| ISSN | 1071-9164 |
| DOIs | |
| Publication status | Published - 2021 |
Bibliographical note
Funding Information:
Mandeep R. Mehra reports payments made to my institution from Abbott for consulting; Consultant fees from Medtronic, Janssen, Mesoblast, Portola, Bayer, Triple Gene, and Baim Institute for Clinical Research; and Scientific Advisory Board Member for NuPulseCV, Leviticus, and FineHeart. Finn Gustafsson reports consulting honoraria from Abbott, Bayer, Pfizer, Alnylam, Boehringer-Ingelheim, Amgen, Pharmacosmos and Idorisa for consulting and speaker fees from Novartis, Astra-Zeneca, Orion Pharma, and Vifor.
- advanced heart failure, early referral, innovation, LVAD, outcomes
Research areas
ID: 301618615